{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:gilan-pharmaceutical-company",
    "identifier": "hg:company:gilan-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Gilan Pharmaceutical Company",
    "slug": "gilan-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/gilan-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/gilan-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/gilan-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Gilan Pharmaceutical Company Gilan Pharmaceutical Company requires additional verification because public sources did not clearly confirm a current official website, ticker, or listed-market status under this exact English name. In the Hormuz Group company graph, it should be treated as a provisional healthcare-manufacturing entry connected to Gilan's broader pharmaceutical and medical-industry base, rather than as a fully verified listed or private company. Gilan Pharmaceutical is relevant only as a provisional profile until the exact legal entity is confirmed. If verified, it may help investors assess pharmaceutical manufacturing capacity in Gilan, regional healthcare supply, medicine distribution, raw-material import dependence, and technology gaps in smaller drug producers. Due diligence should prioritize legal-name confirmation, registry status, factory location, product registrations, ownership, GMP certification, operating continuity, ticker status, and whether the intended company is distinct from Sobhan, Caspian Tamin, or other Rasht-based pharmaceutical producers. Gilan Pharmaceutical Company is treated as a provisional pharmaceutical manufacturing profile connected to medicine production, healthcare supply, pharmacy distribution, hospital demand, raw-material procurement, and regulated pharmaceutical manufacturing in Gilan Province. Its exact product categories, current operating company, and market status require further verification. province: Gilan industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Rasht",
    "published_at": "2026-06-28T20:21:36+00:00",
    "modified_at": "2026-06-28T20:21:36+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 192,
                "name": "Gilan",
                "slug": "gilan",
                "url": "https://hormuz.group/provinces/gilan/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 478,
                "name": "Rasht",
                "slug": "rasht",
                "url": "https://hormuz.group/cities/rasht/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Gilan",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Rasht"
    },
    "fields_summary": {
        "legal_name": "Gilan Pharmaceutical Company",
        "website": "",
        "city": "Rasht, Gilan Province, Iran",
        "ticker_symbol": "",
        "listing_status": "unknown",
        "products_services": "Gilan Pharmaceutical Company is treated as a provisional pharmaceutical manufacturing profile connected to medicine production, healthcare supply, pharmacy distribution, hospital demand, raw-material procurement, and regulated pharmaceutical manufacturing in Gilan Province. Its exact product categories, current operating company, and market status require further verification.",
        "export_relevance": "unknown",
        "short_profile": "Gilan Pharmaceutical Company requires additional verification because public sources did not clearly confirm a current official website, ticker, or listed-market status under this exact English name. In the Hormuz Group company graph, it should be treated as a provisional healthcare-manufacturing entry connected to Gilan's broader pharmaceutical and medical-industry base, rather than as a fully verified listed or private company.",
        "investment_relevance": "Gilan Pharmaceutical is relevant only as a provisional profile until the exact legal entity is confirmed. If verified, it may help investors assess pharmaceutical manufacturing capacity in Gilan, regional healthcare supply, medicine distribution, raw-material import dependence, and technology gaps in smaller drug producers. Due diligence should prioritize legal-name confirmation, registry status, factory location, product registrations, ownership, GMP certification, operating continuity, ticker status, and whether the intended company is distinct from Sobhan, Caspian Tamin, or other Rasht-based pharmaceutical producers."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Gilan Pharmaceutical Company",
        "city": "Rasht, Gilan Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "unknown",
        "verification_status": "needs_update",
        "data_confidence": "low",
        "listing_status": "unknown",
        "last_updated": "28/06/2026",
        "website": "",
        "products_services": "Gilan Pharmaceutical Company is treated as a provisional pharmaceutical manufacturing profile connected to medicine production, healthcare supply, pharmacy distribution, hospital demand, raw-material procurement, and regulated pharmaceutical manufacturing in Gilan Province. Its exact product categories, current operating company, and market status require further verification.",
        "short_profile": "Gilan Pharmaceutical Company requires additional verification because public sources did not clearly confirm a current official website, ticker, or listed-market status under this exact English name. In the Hormuz Group company graph, it should be treated as a provisional healthcare-manufacturing entry connected to Gilan's broader pharmaceutical and medical-industry base, rather than as a fully verified listed or private company.",
        "investment_relevance": "Gilan Pharmaceutical is relevant only as a provisional profile until the exact legal entity is confirmed. If verified, it may help investors assess pharmaceutical manufacturing capacity in Gilan, regional healthcare supply, medicine distribution, raw-material import dependence, and technology gaps in smaller drug producers. Due diligence should prioritize legal-name confirmation, registry status, factory location, product registrations, ownership, GMP certification, operating continuity, ticker status, and whether the intended company is distinct from Sobhan, Caspian Tamin, or other Rasht-based pharmaceutical producers.",
        "source_note": "Based on limited public company, pharmaceutical-sector, regional, and market-context information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 28
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 27
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 12
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 379
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 433
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 627
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 196
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on limited public company, pharmaceutical-sector, regional, and market-context information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [
            "website"
        ],
        "missing_required_count": 1,
        "verification_status": "needs_update",
        "data_confidence": "low",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 57
    },
    "verification": {
        "verification_status": "needs_update",
        "data_confidence": "low",
        "last_updated": "28/06/2026"
    }
}